Patrick-Brown, Thale D. J. H. http://orcid.org/0000-0002-5002-0195
Bourner, Josephine
Kali, Sabrina
Trøseid, Marius
Yazdanpanah, Yazdan
Olliaro, Piero
Olsen, Inge Christoffer
Funding for this research was provided by:
UK Foreign, Commonwealth and Development Office and Wellcome (215091/Z/18/Z)
Bill and Melinda Gates Foundation (OPP1209135)
Horizon 2020 Framework Programme (101015736)
French Health Ministry (JORF No.0267 du novembre 2022 – ANRS0258s MOSAIC)
Klinbeforsk (2020208)
ANRS-MIE
Article History
Received: 25 January 2023
Accepted: 11 December 2023
First Online: 2 January 2024
Declarations
:
: All trials referred to in this paper have received full ethics approval in all countries they are running in. The EU-SolidAct/Bari-SolidAct project is registered in the European Medicine’s Agency’s CTIS system under number 2022-500385-99-00, and under the old CTR system with EudraCT number 2021-000541-41. The AXL-SolidAct project is registered in the CTIS system under number 2022-500363-12-00. The MOSAIC trial is registered in the CTIS system under number 2022-501132-42-00.
: Not applicable.
: The authors declare that they have no competing interests. ICMJE Conflict of Interest disclosure forms are on file and available upon request.